Biocon Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/05/2026 ,inter alia, to consider and approve Update on prior intimation of Board ....
BIOCON · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Biocon Ltd has scheduled a Board meeting on May 7, 2026, to consider investing in its unlisted material subsidiary Biocon Biologics Limited (BBL). The investment will be structured as purchase or acquisition of BBL equity shares for consideration other than cash. Biocon will issue fully paid-up equity shares on a preferential allotment basis through private placement, with the issue price determined in accordance with SEBI ICDR Regulations, 2018. The transaction requires shareholder approval, which will be sought via Postal Ballot. This is an update to the earlier intimation dated April 23, 2026.
This indicates potential restructuring or consolidation within the Biocon group through a share-swap arrangement. Shareholders should watch for the Postal Ballot notice as approval is needed, and the preferential allotment will dilute existing shareholding.